U S PHYSICAL THERAPY INC /NV (USPH) Current Ratio
- Current ratio · latest quarter: Value 1.27×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.27× | Current assets / current liabilities. $139.68M ÷ $109.91M ≈ 1.27× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 139.68M USD | Assets, Current |
| Current obligations | 109.91M USD | Liabilities, Current |
| Cash and equivalents | 24.89M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 69.60M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | (m) | |
| Borrowing debt due within one year | 4.56M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $139.68M | $109.91M | $24.89M | (m) | $69.60M | (m) | (m) | $4.56M | 1.27× |
| 2026-03-31 | $139.11M | $117.30M | $28.44M | (m) | $69.08M | (m) | (m) | $10.80M | 1.19× |
| 2025-12-31 | $139.99M | $139.04M | $35.57M | (m) | $64.25M | (m) | (m) | $9.87M | 1.01× |
| 2025-09-30 | $138.44M | $115.08M | $31.10M | (m) | $67.63M | (m) | (m) | $8.80M | 1.20× |
| 2025-06-30 | $140.53M | $118.84M | $34.09M | (m) | $65.96M | (m) | (m) | $8.17M | 1.18× |
| 2025-03-31 | $145.35M | $123.80M | $39.18M | (m) | $64.76M | (m) | (m) | $9.26M | 1.17× |
| 2024-12-31 | $137.58M | $116.28M | $41.36M | (m) | $59.04M | (m) | (m) | $11.00M | 1.18× |
| 2024-09-30 | $204.87M | $115.30M | $116.96M | (m) | $57.02M | (m) | (m) | $9.61M | 1.78× |
| 2024-06-30 | $201.68M | $107.10M | $112.91M | (m) | $54.66M | (m) | (m) | $9.70M | 1.88× |
| 2024-03-31 | $221.14M | $102.54M | $132.29M | (m) | $55.36M | (m) | (m) | $9.22M | 2.16× |
| 2023-12-31 | $233.38M | $102.19M | $152.82M | (m) | $51.87M | (m) | (m) | $7.69M | 2.28× |
| 2023-09-30 | $228.50M | $82.36M | $147.69M | (m) | $52.96M | (m) | (m) | $7.55M | 2.77× |
| 2023-06-30 | $241.80M | $85.82M | $160.74M | (m) | $54.28M | (m) | (m) | $7.53M | 2.82× |
| 2023-03-31 | $117.79M | $90.83M | $32.60M | (m) | $56.65M | (m) | (m) | $7.73M | 1.30× |
| 2022-12-31 | $111.27M | $85.49M | $31.59M | (m) | $51.93M | (m) | (m) | $7.86M | 1.30× |
| 2022-09-30 | $112.89M | $81.49M | $37.91M | (m) | $49.75M | (m) | (m) | $7.49M | 1.39× |
| 2022-06-30 | $121.85M | $85.11M | $48.57M | (m) | $50.55M | (m) | (m) | $4.78M | 1.43× |
| 2022-03-31 | $95.84M | $89.02M | $24.23M | (m) | $49.34M | (m) | (m) | $799.00K | 1.08× |
| 2021-12-31 | $95.17M | $83.48M | $28.57M | (m) | $46.27M | (m) | (m) | $830.00K | 1.14× |
| 2021-09-30 | $79.42M | $81.67M | $19.19M | (m) | $46.46M | (m) | (m) | $672.00K | 0.97× |
| 2021-06-30 | $79.70M | $75.38M | $20.42M | (m) | $45.14M | (m) | (m) | $1.02M | 1.06× |
| 2021-03-31 | $75.80M | $90.83M | $17.94M | (m) | $45.39M | (m) | (m) | $5.08M | 0.83× |
| 2020-12-31 | $87.64M | $93.49M | $32.92M | (m) | $41.91M | (m) | (m) | $4.90M | 0.94× |
| 2020-09-30 | $82.64M | $93.20M | $30.13M | (m) | $39.44M | (m) | (m) | $5.00M | 0.89× |
| 2020-06-30 | $92.14M | $87.35M | $43.55M | (m) | $36.03M | (m) | (m) | $4.63M | 1.05× |
| 2020-03-31 | $148.67M | $71.15M | $89.55M | (m) | $42.65M | (m) | (m) | $728.00K | 2.09× |
| 2019-12-31 | $85.39M | $60.56M | $23.55M | (m) | $46.23M | (m) | (m) | $728.00K | 1.41× |
| 2019-09-30 | $92.53M | $62.80M | $27.86M | (m) | $47.12M | (m) | (m) | $718.00K | 1.47× |
| 2019-06-30 | $107.01M | $57.02M | $34.86M | (m) | $44.92M | (m) | (m) | $690.00K | 1.88× |
| 2019-03-31 | $81.16M | $68.93M | $20.24M | (m) | $48.44M | (m) | (m) | $1.07M | 1.18× |
| 2018-12-31 | $79.21M | $41.95M | $23.37M | (m) | $44.75M | (m) | (m) | $1.43M | 1.89× |
| 2018-09-30 | $90.66M | $46.96M | $32.24M | (m) | $43.90M | (m) | (m) | $4.77M | 1.93× |
| 2018-06-30 | $86.41M | $41.89M | $27.15M | (m) | $45.42M | (m) | (m) | $4.82M | 2.06× |
| 2018-03-31 | $75.59M | $45.38M | $19.81M | (m) | $46.23M | (m) | (m) | $5.32M | 1.67× |
| 2017-12-31 | $77.08M | $39.55M | $21.93M | (m) | $44.71M | (m) | (m) | $4.04M | 1.95× |
| 2017-09-30 | $73.42M | $35.99M | $17.42M | (m) | $43.56M | (m) | (m) | $2.75M | 2.04× |
| 2017-06-30 | $79.61M | $35.19M | $20.24M | (m) | $46.77M | (m) | (m) | $2.35M | 2.26× |
| 2017-03-31 | $78.57M | $34.03M | $25.15M | (m) | $43.24M | (m) | (m) | $1.22M | 2.31× |
| 2016-12-31 | $65.96M | $24.62M | $20.05M | (m) | $38.84M | (m) | (m) | $1.23M | 2.68× |
| 2016-09-30 | $67.43M | $26.38M | $15.02M | (m) | $38.52M | (m) | (m) | $986.00K | 2.56× |
| 2016-06-30 | $70.94M | $28.98M | $20.45M | (m) | $39.36M | (m) | (m) | $1.04M | 2.45× |
| 2016-03-31 | $68.55M | $24.18M | $19.21M | (m) | $38.22M | (m) | (m) | $1.25M | 2.83× |
| 2015-12-31 | $60.20M | $19.01M | $15.78M | (m) | $36.23M | (m) | (m) | $775.00K | 3.17× |
| 2015-09-30 | $63.66M | $21.36M | $20.56M | (m) | $35.11M | (m) | (m) | $1.41M | 2.98× |
| 2015-06-30 | $55.65M | $21.70M | $12.97M | (m) | $34.83M | (m) | (m) | $800.00K | 2.56× |
| 2015-03-31 | $55.90M | $21.40M | $14.56M | (m) | $34.67M | (m) | (m) | $932.00K | 2.61× |
| 2014-12-31 | $54.85M | $25.50M | $14.27M | (m) | $32.89M | (m) | (m) | $883.00K | 2.15× |
| 2014-09-30 | $56.62M | $21.83M | $15.82M | (m) | (m) | (m) | (m) | $850.00K | 2.59× |
| 2014-06-30 | $51.85M | $22.80M | $12.93M | (m) | (m) | (m) | (m) | $850.00K | 2.27× |
| 2014-03-31 | $54.25M | $19.34M | $16.76M | (m) | (m) | (m) | (m) | $775.00K | 2.80× |
| 2013-12-31 | $49.66M | $23.17M | $12.90M | (m) | (m) | (m) | (m) | $825.00K | 2.14× |
| 2013-09-30 | $45.16M | $16.66M | $12.12M | (m) | (m) | (m) | (m) | $575.00K | 2.71× |
| 2013-06-30 | $41.43M | $17.37M | $10.29M | (m) | (m) | (m) | (m) | $800.00K | 2.38× |
| 2013-03-31 | $44.72M | $13.90M | $10.28M | (m) | (m) | (m) | (m) | $659.00K | 3.22× |
| 2012-12-31 | $45.32M | $16.31M | $11.67M | (m) | (m) | (m) | (m) | $459.00K | 2.78× |
| 2012-09-30 | $44.06M | $14.95M | $10.68M | (m) | (m) | (m) | (m) | $609.00K | 2.95× |
| 2012-06-30 | $44.64M | $16.21M | $8.81M | (m) | (m) | (m) | (m) | $609.00K | 2.75× |
| 2012-03-31 | $47.12M | $12.52M | $10.44M | (m) | (m) | (m) | (m) | $483.00K | 3.77× |
| 2011-12-31 | $45.67M | $16.32M | $9.98M | (m) | (m) | (m) | (m) | $433.00K | 2.80× |
| 2011-09-30 | $45.84M | $13.69M | (m) | (m) | (m) | (m) | (m) | $533.00K | 3.35× |
| 2011-06-30 | $44.25M | $14.69M | (m) | (m) | (m) | (m) | (m) | $434.00K | 3.01× |
| 2010-12-31 | $39.28M | $14.23M | $9.18M | (m) | (m) | (m) | (m) | $250.00K | 2.76× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |